Back to state act
Description
On 13 June 2024, the Biomedical Advanced Research and Development Authority (BARDA) awarded USD 453 million to Vaxart Inc to support the planning and execution of a Phase 2b clinical trial for their o...
Sign in to see full description
Intervention Details
Intervention Type
State aid, unspecified
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
13 Jun 2024
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 1 products
Threads
See all
This intervention is not part of any Thread yet.